Amneal’s latest innovations in access and affordability
Our Biosciences business delivers a growing portfolio of biosimilars and specialty injectable products across multiple therapeutic areas, including movement disorders and oncology. The business delivers value for patients and providers through increased choice, access, and affordability when these highly specialized and typically high-cost medicines are the appropriate option for care. Biosciences products are marketed through our deeply experienced U.S.-based Regional and Key Account Managers, who support hospitals, clinics, and specialty health care providers specializing in various therapeutic categories.
© 2023 Amneal Pharmaceuticals LLC. All rights reserved.